california dmhc glp-1 coverage exclusion allowed has ended adult Medi-Cal for popular weight loss medications, leaving thousands of patients worried about losing treatment that helped control diabetes, prevent disease and change their California Medi-Cal halts GLP-1 obesity

This study provides novel findings indicating that the GLP-1R found in key neuronal pathways of the brain that regulate energy balance likely mediates liraglutide-induced weight loss

Last reviewed: June 18, 2026 Last updated: June 18, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations

Oral semaglutide drops and sublingual formulations may actually worsen the local sensation of dry mouth because the medication contacts oral tissues directly

Drokhlyansky et al., 2020)

More than 30 million Americans are using some form of weight loss drug, often with significant results

Lancet 394(10207):14671480